ArticleCancer gene therapy2025

Single-cell profiling of peripheral blood mononuclear cells from patients treated with oncolytic adenovirus TILT-123 reveals baseline immune status as a predictor of therapy outcomes.

Tatiana V Kudling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.